Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
State Street SPDR S&P Insurance ETF
KIE
$678M
| $278K | ﹤0.01% |
+4,597
| New | +$267K |
|
3777
Resources Connection
RGP
$145M
| $278K | ﹤0.01% |
42,534
-15,518
| -27% | -$120K |
|
3778
Funko
FNKO
$339M
| $277K | ﹤0.01% |
40,435
-10,211
| -20% | -$119K |
|
|
BLDP
3779
Ballard Power Systems
BLDP
$793M
| $275K | ﹤0.01% |
249,957
+199,500
| +395% | +$281K |
|
|
ESSA
3780
DELISTED
ESSA Bancorp
ESSA
| $275K | ﹤0.01% |
14,566
-1,015
| -7% | -$20.5K |
|
3781
The Joint Corp
JYNT
$121M
| $274K | ﹤0.01% |
21,963
-5,417
| -20% | -$61.3K |
|
3782
DocGo
DCGO
$65.8M
| $273K | ﹤0.01% |
103,492
-50,964
| -33% | -$204K |
|
3783
Leslie's
LESL
$7.05M
| $273K | ﹤0.01% |
18,565
-11,852
| -39% | -$363K |
|
3784
C&F Financial
CFFI
$284M
| $273K | ﹤0.01% |
4,052
+2,722
| +205% | +$204K |
|
|
URG
3785
Ur-Energy
URG
$529M
| $272K | ﹤0.01% |
403,726
-175,958
| -30% | -$172K |
|
|
NESR
3786
National Energy Services Reunited Corp
NESR
$3.6B
| $272K | ﹤0.01% |
36,910
-11,105
| -23% | -$95.9K |
|
|
IAUX
3787
i-80 Gold Corp
IAUX
$1.44B
| $271K | ﹤0.01% |
466,238
-157,741
| -25% | -$102K |
|
3788
Citizens Financial Services
CZFS
$402M
| $271K | ﹤0.01% |
4,716
-2,174
| -32% | -$130K |
|
3789
CALL
uniQure
QURE
$3.2B
| $270K | ﹤0.01% |
25,500
-32,500
| -56% | -$456K |
|
3790
Ginkgo Bioworks
DNA
$494M
| $270K | ﹤0.01% |
47,416
-6,750
| -12% | -$68.8K |
|
3791
Plumas Bancorp
PLBC
$443M
| $270K | ﹤0.01% |
6,244
-2,007
| -24% | -$90K |
|
3792
Gossamer Bio
GOSS
$84.3M
| $270K | ﹤0.01% |
245,100
+245,000
| +245,000% | +$283K |
|
3793
RBB Bancorp
RBB
$464M
| $269K | ﹤0.01% |
16,297
-8,200
| -33% | -$149K |
|
3794
Precigen
PGEN
$2.36B
| $268K | ﹤0.01% |
179,835
-63,064
| -26% | -$99.3K |
|
|
BHR
3795
Braemar Hotels & Resorts
BHR
$140M
| $268K | ﹤0.01% |
107,481
-32,781
| -23% | -$89.5K |
|
|
CLPR
3796
Clipper Realty
CLPR
$52.5M
| $267K | ﹤0.01% |
69,597
-5,981
| -8% | -$25.1K |
|
3797
ProShares Short VIX Short-Term Futures ETF
SVXY
$234M
| $266K | ﹤0.01% |
5,810
| – | – |
|
|
PHLT
3798
DELISTED
Performant Healthcare Inc
PHLT
| $265K | ﹤0.01% |
89,465
-33,904
| -27% | -$87.9K |
|
3799
Corvus Pharmaceuticals
CRVS
$1.28B
| $265K | ﹤0.01% |
83,231
-22,788
| -21% | -$107K |
|
|
FOLD
3800
CALL
DELISTED
Amicus Therapeutics
FOLD
| $264K | ﹤0.01% |
+32,400
| New | +$300K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.